Evidence map›Paper›PMID 30780152›Full record

ArticlePediatric research2019

Surfactant replacement therapy for respiratory distress syndrome in preterm infants: United Kingdom national consensus.

Sujoy Banerjee, Ramon Fernandez, Grenville F Fox, Kevin C W Goss, Helen Mactier, Peter Reynolds, David G Sweet, Charles C Roehr

Abstract readConsensus Statement
In one paragraph

Article in Pediatric research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. High vs low CPAP strategy with aerosolized calfactant in preterm infants with respiratory distress syndrome.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Trial
  4. Review
  5. Review
  6. Short-term outcomes associated with surfactant use in respiratory distress in late preterm to early term infants.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  7. Review
  8. Review
  9. Which surfactant is cost-effective in Neonatal Respiratory Distress Syndrome?Cost effectiveness and resource allocation : C/E · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Prophylactic surfactant therapy in the era of less invasive surfactant delivery.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  15. Article
  16. Article
  17. Less invasive surfactant administration methods: Who, what and how.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Review
  18. Review
  19. Review
  20. RDS-NExT workshop: consensus statements for the use of surfactant in preterm neonates with RDS.Journal of perinatology : official journal of the California Perinatal Association · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Sujoy BanerjeeSingleton Hospital, Swansea, UK.
Ramon FernandezRoyal Sussex County Hospital, Brighton, UK.
Grenville F FoxEvelina London Children's Hospital, London, UK.
Kevin C W GossLeeds Centre for Newborn Care, Leeds Children's Hospital, Leeds, UK.
Helen MactierPrincess Royal Maternity, Glasgow, UK.
Peter ReynoldsSt. Peter's Hospital, Ashford and St. Peter's Hospitals NHS Foundation Trust, Chertsey, UK.
David G SweetRoyal Jubilee Maternity Hospital, Belfast, UK.
Charles C RoehrMedical Sciences Division, University Department of Paediatrics, University of Oxford, Oxford, UK. charles.roehr@paediatrics.ox.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological ProductsBirth WeightContinuous Positive Airway PressureHumansInfant, NewbornInfant, PrematureLung InjuryNeonatologyOxygenPhospholipidsRandomized Controlled Trials as TopicRespiratory Distress Syndrome, NewbornSurface-Active AgentsUnited KingdomBiological ProductsOxygenPhospholipidsporactant alfaSurface-Active Agents

Identifiers

PMID30780152
PMCPMC6760556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.